Article
ELK1 Enhances Pancreatic Cancer Progression Via LGMN and Correlates with Poor Prognosis
13 Dec 2021
Abstract excerpt
Pancreatic cancer is one of the most lethal cancers and its prognosis is extremely poor. Clarification of molecular mechanisms and identification of prognostic biomarkers are urgently needed. Though we previously found that LGMN was involved in pancreatic carcinoma progression, the upstream regulation of LGMN remains unknown. We used reliable software to search for the potential transcription factors that may be...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
